- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04187989
Social Media Intervention for Cannabis Use in Emerging Adults
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- self-report using cannabis at least 3 time per week or more often in the past month
- active Facebook profile
- view and click on a social media ad
Exclusion Criteria:
- fail identity verification based on 1) Internet Protocol (IP) addresses, 2) survey time completion, 3) repeat attempts, 4) survey responses, and 5) photo identification via a timestamped selfie sent to the research staff.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Social Media Intervention
Facebook page that will deliver health information focused on increasing well-being and reducing risky behaviors.
|
Information will be posted by e-coaches.
You can interact with the e-coaches as well as other study members in your group.
|
No Intervention: Control
An Attention-Control E-News (control) condition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of Cannabis Use as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 3-months post baseline
|
30-day TLFB self-report will be used to assess total number of days of cannabis use.
|
3-months post baseline
|
Frequency of Cannabis Use as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 6-months post baseline
|
30-day TLFB self-report will be used to assess total number of days of cannabis use.
|
6-months post baseline
|
Quantity of Cannabis Used as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 3-months post baseline
|
30-day Timeline Follow-Back (TLFB) self-report will be used to assess quantity (grams) of cannabis consumed.
|
3-months post baseline
|
Quantity of Cannabis Used as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 6-months post baseline
|
30-day Timeline Follow-Back (TLFB) self-report will be used to assess quantity (grams) of cannabis consumed.
|
6-months post baseline
|
Consequences of Cannabis Use as Measured by the Marijuana Adolescent Consequences Questionnaire Using Dichotomous Response Scale as Previously Described Throughout This Trial Registration.
Time Frame: 3-months post-baseline
|
Marijuana Adolescent Consequences Questionnaire will be used to assess past 3 month consequences of cannabis use. Consequences are measured by report of number of times incidents from the list of 26 items (e.g., quality of work suffered, had less energy, etc.) resulted from cannabis use. Responses will be dichotomized (0 = never, 1= greater than never) and summed for a total score reflecting total number of consequences. Response scale: Never 1-2 times 3-5 times 6-10 times More than 10 times Minimum score =0, maximum = 26. Higher score = more consequences. |
3-months post-baseline
|
Consequences of Cannabis Use as Measured by the Marijuana Adolescent Consequences Questionnaire
Time Frame: 6-months post-baseline
|
Marijuana Adolescent Consequences Questionnaire will be used to assess past 3 month consequences of cannabis use. Consequences are measured by report of number of times incidents from the list of 26 items (e.g., quality of work suffered, had less energy, etc.) resulted from cannabis use. Responses will be dichotomized (0 = never, 1= greater than never) and summed for a total score reflecting total number of consequences. Response scale: Never 1-2 times 3-5 times 6-10 times More than 10 times Minimum score =0, maximum = 26. Higher score = more consequences. |
6-months post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Risk of Cannabis Use as Measured by 2 Modified Items From the Monitoring the Future Survey
Time Frame: 3-months post-baseline
|
Two items rating current opinion on a scale from "no risk" to "great risk" of their perceived risk harm from occasional cannabis use and regular use. Items are-- How much do you think people risk harming themselves (physically or in other ways), if they:
Response options are:
Answers from both items are added together. The total range of two items summed can be 2-8. Higher totals indicate higher perceived risk. |
3-months post-baseline
|
Perceived Risk of Cannabis Use as Measured by Modified Items From the Monitoring the Future Survey
Time Frame: 6-months post-baseline
|
Two items rating current opinion on a scale from "no risk" to "great risk" of their perceived risk harm from occasional cannabis use and regular use. Items are-- How much do you think people risk harming themselves (physically or in other ways), if they:
Response options are:
Answers from both items are added together. The total range of two items summed can be 2-8. Higher totals indicate higher perceived risk. |
6-months post-baseline
|
Peer Approval/Disapproval of Cannabis Use as Measured by Item Modified From Monitoring the Future Survey
Time Frame: 3 months post-baseline
|
One item rating of current perception of whether their close friends would disapprove of their cannabis use (regardless of how much they use), rated as:
|
3 months post-baseline
|
Peer Approval/Disapproval of Cannabis Use as Measured by Item Modified From Monitoring the Future Survey
Time Frame: 6 months post-baseline
|
One item rating of current perception of whether their close friends would disapprove of their cannabis use (regardless of how much they use), rated as: 1 Not disapprove 2 Disapprove 3 Strongly disapprove
|
6 months post-baseline
|
Cannabis Impaired Driving as Measured by 5 Items From the Modified Young Adult Driving Questionnaire
Time Frame: 3 months post-baseline
|
Five items from the modified Young Adult Driving Questionnaire will be used to assess past 3 month driving under the influence of cannabis. Response values will be summed for a total score. In the PAST 3 MONTHS...how many times did you drive within one hour after using marijuana or marijuana products containing THC?
Response options: 0= Never
|
3 months post-baseline
|
Cannabis Impaired Driving as Measured by 5 Items From the Modified Young Adult Driving Questionnaire
Time Frame: 6 months post-baseline
|
Five items from the modified Young Adult Driving Questionnaire will be used to assess past 3 month driving under the influence of cannabis. Response values will be summed for a total score. In the PAST 3 MONTHS...how many times did you drive within one hour after using marijuana or marijuana products containing THC?
Response options: 0= Never
|
6 months post-baseline
|
Other Drug Use as Measured by Items Modified From Monitoring the Future Survey
Time Frame: 3 months post-baseline
|
Items from the Monitoring the Future Survey will be used to assess past 30 day use of 6 other substances - substances used and number of times of use. Response values will be summed for a total score using mid-point of the range scoring. Substances assessed include: hallucinogens, opioids, stimulants, sedatives, lsd, ecstasy Response scale: 0 0 Occasions
|
3 months post-baseline
|
Other Drug Use as Measured by Items Modified From Monitoring the Future Survey
Time Frame: 6 months post-baseline
|
Items from the Monitoring the Future Survey will be used to assess past 30 day use of 6 other substances - substances used and number of times of use. Response values will be summed for a total score using mid-point of the range scoring. Substances assessed include: hallucinogens, opioids, stimulants, sedatives, lsd, ecstasy Response scale: 0 0 Occasions
|
6 months post-baseline
|
Frequency of Alcohol Consumption as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 3 months post-baseline
|
30-day TLFB self-report will be used to assess total number of days of alcohol consumption.
|
3 months post-baseline
|
Frequency of Alcohol Consumption as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 6 months post-baseline
|
30-day TLFB self-report will be used to assess total number of days of alcohol consumption.
|
6 months post-baseline
|
Quantity of Alcohol Consumption as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 3 months post-baseline
|
30-day TLFB self-report will be used to assess the quantity of alcohol consumed.
|
3 months post-baseline
|
Quantity of Alcohol Consumption as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 6 months post-baseline
|
30-day TLFB self-report will be used to assess the quantity of alcohol consumed.
|
6 months post-baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Erin Bonar, University of Michigan
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00152202
- R34DA045712 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis Use
-
Centre hospitalier de l'Université de Montréal...RecruitingCannabis | Cannabis Dependence | Cannabis Use | Cannabis Smoking | Cannabis Use, UnspecifiedCanada
-
The University of Tennessee, KnoxvilleColorado State UniversityActive, not recruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Elias DakwarRecruitingAddiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use DisorderUnited States
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
Oregon Research InstituteCompletedCannabis Use Disorder, Mild | Cannabis Use Disorder, ModerateUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)Not yet recruitingTobacco Use | Cannabis | Cannabis Use | Vaping | THC | Cannabis SmokingUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingBipolar Disorder | Cannabis Use | Bipolar I Disorder | Cannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe | Bipolar II Disorder | Schizoaffective Disorder, Bipolar TypeUnited States
-
Hartford HospitalYale UniversityNot yet recruitingMarijuana Use | Cannabis Use | Cannabis Intoxication
-
McMaster UniversityCenter for Medicinal Cannabis ResearchNot yet recruitingCannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe
Clinical Trials on Social Media Intervention
-
University of California, IrvineUniversity of California, Los AngelesCompleted
-
University of California, San DiegoNational Institute of Nursing Research (NINR); Brown UniversityActive, not recruiting
-
The University of Hong KongLok Sin Tong Benevolent Society, KowloonCompleted
-
University of California, Los AngelesBrown University; Asociación Civil Impacta Salud y Educación, Peru; The Fenway...Completed
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; The Oscar G. & Elsa S. Mayer Family FoundationCompleted
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR); Applied Health Research CentreUnknownColorectal Cancer | Cancer Screening
-
Emory UniversityNational Institute of Mental Health (NIMH); University of KwaZuluCompletedHIV-1-infection | Adolescent BehaviorSouth Africa
-
University of BelgradeCompletedPhysical ActivitySerbia
-
University of California, San FranciscoHopeLab Foundation; Tobacco Related Disease Research Program; Rescue AgencyActive, not recruitingVapingUnited States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed